June 13-26, 2003
Back Issues
IN THIS ISSUE
Board funds raises, seeks more for faculty
Child prodigy now U.Va. grad student
North Fork gets three new tenants
Digest -- U.Va. news daily

Headlines @ U.Va.

From resources to rescues
Q: ‘Are we as diverse as we say we are?’
Decade Plan
New VQR editor will seek next generation of readers
Heritage Repertory Theatre presents five plays this summer
Fiber art by aboriginal women now on display
Rain delays work

Digest -- U.Va. News Daily

row of hard hats
Arena work forces Massie Road closings
Motorists traveling between the University Hall area to North Grounds will have to take the long way around for most of the summer. Two months of road work will close sections of Massie and Copeley roads in order to install new electrical duct banks to supply power to the new John Paul Jones Arena.
(Top News Daily, May 29)

Meeting brings state’s top scientists here
Stem-cell research, nanotechnology and even the Lewis & Clark expedition shared the spotlight with a Nobel laureate during the last week in May — all part of the annual meeting of the Virginia Academy of Sciences, hosted by the University. The keynote address was given by 2002 Nobel laureate in chemistry John B. Fenn of VCU.
(Top News Daily, May 26)

Study: Gallstone procedure safe for pregnant women
A study by doctors at the Health System has found that a form of X-ray therapy for treating gallstones, called endoscopic retrograde cholangiopancreatography, or ERCP, is safe for pregnant women. “If pregnant women have stones in the bile duct or related disease and need immediate intervention, this study shows that the safest way is ERCP with minimal radiation and fetal monitoring,” said Dr. Michel Kahaleh, a gastroenterologist and assistant professor of internal medicine. If left untreated, gallstones can have serious implications for both the fetus and the mother.
(Top News Daily, June 9)

Defense Dept. grant boosts prostate cancer study
The Department of Defense has awarded a U.Va. Health System research team $500,000 to study the spread of prostate cancer to bone tissue, and to investigate promising preventive treatments. The study is led by Gary Balian, a professor of orthopedic research and professor of biochemistry and molecular biology at U.Va. Jay Fox, professor of microbiology and assistant dean of research, is also involved in the research, along with Robert Sikes, a former U.Va. professor who is now a professor of biological sciences at the University of Delaware.
(Top News Daily, June 2)

Angioplasty procedure improved
If you think of balloon angioplasty as sort of plunging of clogged arteries, then a stent is a piece of scaffolding designed to keep the arterial walls propped up and blood flowing freely afterward. However, in 8 to 25 percent of cases, the arteries became clogged again, a process called restenosis. Now the Health System is offering a new kind of stent, coated with an antibiotic called sirolimus, that helps prevent re-clogging. The first drug-eluting stent at U.Va. was inserted in a patient’s heart vessel on May 21 by Dr. Michael Ragosta, director of interventional cardiology and associate professor of internal medicine. “The drug-eluting stents represent a major breakthrough in the treatment of patients with coronary artery disease,” Ragosta said.
(Top News Daily, June 3)


CURRENT ISSUE

© Copyright 2003 by the Rector and Visitors
of the University of Virginia

UVa Home Page UVa Events Calendar Top News UVa Home Page